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Abstract
Shape memory polymer (SMP) foams provide a promising new option for
hemorrhage control on the battlefield; however, they lack a mechanism to control wound
infections that can delay healing processes. Adding phenolic acids (PAs) into SMP foams
provides a natural, non-drug option for incorporations of antioxidant and antimicrobial
functionalities that may promote healing. However, PAs lack a systemic characterization
of their structure/property relationships, and their chemical incorporation into SMP foams
may alter their efficacy. In this work, a library of PAs was screened in terms of antioxidant
and antimicrobial properties to provide a full understanding of how their structure affects
their function. Additionally, a subset of PAs was modified with SMP foam analog
monomers (modified PAs, MPAs) and compared to their unmodified counterparts. PA and
MPA antioxidant capabilities were tested in terms of hydrogen peroxide scavenging
capacity, and their antimicrobial activities were evaluated against both gram-positive and
gram-negative bacteria strains. After testing, the PA library was narrowed down from 10
to 5 candidates with the best solubility, antioxidant properties, and antimicrobial properties.
These PAs will be added into SMP foams for use in antimicrobial hemostats.
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1. Introduction
1.1 Clinical Need: Uncontrolled Hemorrhage
Among the potentially survivable battlefield injuries that resulted in death, 80% of them
are due to uncontrolled hemorrhage from major trauma,[1] and up to 50% of deaths occur
outside of hospital.[2] Uncontrolled hemorrhage will lead to great blood loss. Losing 50%
of blood volume without resuscitation is usually fatal, while patients with reduced blood
pressure (those who have lost 30% to 35% of blood volume) are close to death.[3]
Therefore, it is important to quickly mitigate bleeding before one can receive hospital
treatment. Additionally, almost half of traumatic wounds get polymicrobial infections on
the battle field.[4] After infection, the skin-bacteria inflammatory response will release
collagenases and contribute to the collagen degrading, which can delay healing.[5] The
current standard of care is to deliver broad spectrum oral antibiotics after injury,[6] but
this approach is ineffective at eliminating infections and is complicated by the emergence
of drug-resistant bacteria strains.[7] As a result, first-aid treatments for uncontrolled
hemorrhage could be improved if they could provide a localized antimicrobial effect in the
wound.

1.2 Current Solutions: Benefits and Limitations
Currently, the most common medical treatment to control blood loss includes the use
of gauze and tourniquets. Gauze comprises a traditional wound dressing product that
simply covers wounds, and it is used for bleeding from small arteries, veins, and
capillaries with applied pressure. For severe conditions like large arterial bleeding,
tourniquets are used when other hemostasis methods do not work. However, these
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treatments are insufficient for up to 80% of bleeds. Additionally, gauze dressings do not
protect against infection and adhere to the wounds, which makes it difficult and painful to
remove in the subsequent treatments. As for tourniquets, their use is limited to relative
short time frames (<6 hours), as prolonged tourniquet use may lead to wound
complications, including nerve damage and limb loss.[8]
Due to the limitations of gauze and tourniquets, a large number of clinically-available
first-aid treatments for gunshot wounds have been introduced. There are several kinds of
topical hemostatic agents including gelatin foams, thrombin, chitin, chitosan, and oxidized
cellulose. Gelatin foams like Gelfoam (Pfizer), provide a physical matrix for clotting. They
function effectively for small vessel bleeding, and they are biological and absorbable.
However, because of their swelling capability, gelatin foams could not be used in closed
spaces as they can cause nerve compression around the wound; additionally, they do not
protect against infection. Thrombin is able to convert fibrinogen to fibrin to help clots form.
Thrombin dressings are easy to apply and fast acting, but bovine thrombin may cause an
immunologic response. Chitin and chitosan are designed for emergency cases and they
function as a mechanical seal. Chitin dressings are not reliable for severe wounds and
chitosan dressings still have inconsistent results in the animal testing.[9] A promising new
hemostat for gunshot wounds is XStat®, an oxidized cellulose material with ~96 small
sponges that can be injected into a wound. After application, the cellulose micro-sponges
expand quickly and apply pressure to wound walls to cut off blood flow. However, each
sponge must be individually removed from the wound within four hours of application. The
design significantly increases removal times, hemostat removal can cause secondary
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injury and increase infection susceptibility, and this option is limited in prolonged field care
scenarios when frequent dressing changes are not feasible.[10]

1.3 Shape Memory Polymer (SMP) Foams
To address the limitations of current hemostats, we propose to develop a new,
antimicrobial SMP foam. SMP foams are smart materials with multiple biomedical
applications. They are fabricated as expanded, open-porous foams, and they can be
heated, deformed into a secondary, compressed shape, cooled down, and stored for long
time frames. When the environmental temperature is increased above their glass
transition temperature (Tg), SMP foams expand rapidly from the compressed secondary
shape to their original shape. By tuning monomers, chemical formulations, and foaming
parameters, it is possible to customize the material’s thermal, mechanical, and shape
memory properties.[11]
SMP foams have excellent biocompatibility and demonstrate rapid clotting in
aneurysms and peripheral vasculature.[12][13][14][15][16] Previous work has focused on
incorporating new functionalities into SMP foams, including degradability and X-ray
imaging capabilities.[17][18][19][12] Due to their excellent clotting capabilities,
researchers have also previously explored the use of SMP foams for hemorrhage control.
A device was developed that combines SMP foams and iodine-containing poly (ethylene
glycol) (PEG) hydrogels with the capacity for rapid clotting and swelling.[18] The results
showed that the PEG-based SMP foams with iodine maintain shape memory behavior,
increase water absorption, and reduce bacteria viability. However, inclusion of the
hydrogel significantly slowed down foam expansion, which would limit this material’s utility
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on the battlefield. Additionally, research suggests that iodine can be detrimental to wound
healing,[20] which makes exploration of other antimicrobial options a necessity.

1.4 Phenolic Acids
Due to the limitations of traditional antibiotics, there is a growing interest in nondrugbased techniques to fabricate antimicrobial medical devices. Honey has long been used
to treat a variety of wounds, including burns and ulcers that are infected or chronic.[21]
Honey dressings can speed up the healing of pressure wounds and they are also used
to reduce wound stench.[22] These effects are due in part to two kinds of essential
antimicrobial substances in honey, flavonoids and phenolic acids (PAs). It has been
shown that high concentrations of flavonoids and PAs can improve honey’s antimicrobial
capabilities.[22]
PAs contains a carboxylic acid group on their non-active end that enables their
incorporation into the polyurethane SMP foam system; thus, they were selected for further
exploration in these studies. A number of studies have been performed on PA
antimicrobial characterization; however, many studies focus on the use of PAs in relation
to food-borne illnesses and plant pathogens rather than common wound bacteria, such
as E. coli, Staph. epi., and Staph. aureus. No PAs have been characterized against all
strains of interest, many are lacking data on drug-resistant strains, and some of the data
is conflicting (e.g. ferulic and vanillic acids were determined to be effective against E. coli
in studies performed by Merkl et al. but not in those performed by Chatterjee et al.).[23]
[24] Finally, a connection between the PA structure and antimicrobial efficacy is lacking.
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Phenolic acids, as secondary metabolites of plants that could kill microorganisms or
inhibit the growth of bacteria, have been involved in the plant’s antimicrobial mechanisms.
Inhibitory mechanisms of phenolic acids on bacteria growth include, but are not limited to,
destabilizing the bacteria cytoplasmic membrane, altering the permeability of the bacteria
plasma membrane, inhibition of the extracellular microbial enzymes, direct effects on
microbial metabolism, and the deprivation of the substrate required for microbial
growth.[25] Firstly, phenolic acids could affect bacteria cells by changing their
physicochemical surface properties. For example, ferulic acid could promote the
decrease of hydrophobic character of P. aeruginosa.[26] Phenolic acid treatment could
also make gram-positive bacteria strains acquire polar character by measuring the values
of the bacteria’s surface tension components. Phenolic acids have effects on bacteria’s
surface electron receptor of both gram-positive (increased receptor components) and
gram-negative (decreased receptor components) bacteria strains. [26] Secondly,
phenolic acids have effects on the integrity of bacterial cytoplasmic membrane. As the
concentrations of phenolic acids increase, the percentage of cell membrane damage
shows a significant increase. But different phenolic acids have various effects on grampositive and gram-negative bacteria strains. Last but not least, the promotion on the
release of potassium in bacterial cells is also a part of phenolic acid’s antimicrobial
mechanisms. The control groups show more intracellular K+ residual compared with
groups after phenolic acid treatment. And the release of K+ by gram-negative bacteria
strains is more than for the gram-positive bacteria strains.[26]
Previously, cinnamic acid (CA) was incorporated into SMP foams, providing a material
with tunable and clinically-relevant thermal and shape memory properties.[27] Phenolic
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acids including CA don’t need to be released or solubilized from the SMP network to be
functional. Because all PAs are composed of a carboxylic group (for incorporating PAs
into the SMP network) and a benzene ring linked with hydrogen donating groups
(functional group). Therefore, PAs are still effective after tethering to the SMP network,
because only carboxylic group changes during the synthesis process, their functional
group and our desired properties stay. CA-based foams retained high cytocompatibility
and reduced E. coli and Staph. epi. growth, indicating the feasibility of use of PAs to
provide antimicrobial SMPs. In addition to their antimicrobial properties, PAs contain
hydrogen donating groups that can react with oxidants to form resonance-stabilized
phenoxyl radicals and provide antioxidant properties that could further improve healing
outcomes.[23][28][29][30] PAs, as antioxidants, play an essential role in traumatic wound
healing. Because PAs could react with reactive oxygen species (ROS) released from
neutrophils and macrophages.[31] The excessive amount of ROS is always present in
chronic wounds, and a great method to interrupt chronic inflammatory cycle is removing
ROS with antioxidants.[31] In addition to that, ROS are able to create highly oxidizing
environments for traumatic wounds, and the drastically increase of the ROS production
can cause human body’s oxidative stress response leading to critical illness (for example,
organ dysfunction, disseminated intravascular coagulation, and the presence of an acute
phase response).[30][32][33][34] Although ROS are considered to have certain beneficial
antimicrobial properties, prolonged exposure of acute and chronic wounds to high levels
of ROS causes cell damage and inhibits wound healing.[31] Using honey-based PAs, as
free radical scavengers that could block the ROS-induced cytotoxicity, to lower the
concentration of ROS could help decrease lipid peroxidation, damage to DNA, and cell
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death.[31] The long-term goal of our research is to incorporate honey based phenolic
acids into the SMP networks to provide antioxidant and antimicrobial scaffolds. PAcontaining SMPs are expected to promote traumatic healing and lower the risk of bacterial
infection of gram-positive, gram-negative, and drug-resistant bacteria strains.
To reach this goal, the focus of this thesis is to characterize a library of PAs and
establish their structure/property relationships. This work will aid in rational design of PAcontaining biomaterials with desired functionality. Ten PAs were selected to characterize
in terms of antimicrobial and antioxidant properties, Figure 1. The PAs without pendant
hydroxyl (OH) groups on the ring structures (benzoic acid (BA) and CA) are not expected
to demonstrate antioxidant properties. Additional BA- and CA-based PAs were chosen
with varied pendant groups (1 OH group, 1 OH group with 1 or 2 methoxy groups, and 2
OH groups). All selected PAs in this research are expected to have varying degrees of
antimicrobial efficacy, and antioxidant properties are hypothesized to be tied to pendant
group chemistry.
This study fills in understanding the properties of the PAs with pendent group
variations, providing relationships between structure and properties by screening the 10
selected PAs in terms of antimicrobial properties against 5 common pathogenic wound
bacteria and antioxidant properties. An additional consideration is reaction of the
carboxylic acid group on PAs during SMP synthesis and its potential effects on PA
functionality. To address this issue, PAs that were modified with foaming monomer
analogs were characterized in parallel to the unmodified PAs.
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Figure 1. Ten selected PAs and their chemical structures. Top row: CA-based PAs;
Bottom row: BA-based PAs.
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2. Methods and Materials
2.1 Modified Phenolic Acid (MPA) Synthesis
Approximately 3 g of each PA was dried overnight under vacuum and dissolved in
anhydrous dimethyl sulfoxide (DMSO) in a reaction flask at ~0.1 g/ml. Hexyl isocyanate
(HI) (1.1 molar equivalents) was added dropwise to the reaction under anhydrous
conditions. The solution was reacted under nitrogen at 65°C for ~72 hours, or until the
isocyanates were fully reacted, as indicated by a disappearance of the isocyanate peak
at ~2250 cm-1 in the Fourier transform infrared spectroscopy (FTIR) spectra of the
reaction contents.
Complete reaction resulted in separation of the reaction contents into a ‘viscous’ and
‘liquid’ portion. Gravity filtration was applied to the solution with a short stem funnel and
filter paper to separate the viscous and liquid portions. The product was precipitated from
the filtered liquid portion in cold water at a 1:5 volume ratio (liquid portion: cold water).
Then, the solution was centrifuged in 4000 rpm for 15 minutes. The target MPA product
was separated from the solvent and dried under vacuum overnight. The MPA structure
was analyzed using FTIR and nuclear magnetic resonance (NMR) spectroscopy.

2.2 PA and MPA Antioxidant Test
The antioxidant capacity of the 10 PAs and corresponding MPAs was measured
based on their H2O2 scavenging capabilities as previously described. All selected PAs
and MPAs were dissolved in DMSO at 5 mg/ml. A 0.002% H2O2 solution was prepared in
water, a 0.1M phosphate-buffered saline (PBS) solution was prepared in water, dying
agents (phenol red dye and horseradish peroxidase) were dissolved in PBS at 0.2 mg/ml
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and 0.1 mg/ml, respectively, and a 1M sodium hydroxide solution was prepared in water.
Each PA was serially diluted from 5 to 0.078 mg/ml in 10 μl DMSO in wells of a 96-well
plate, as shown in Figure 2. Blank solutions (10 ul DMSO) were also included in each
plate. Then, 10 μl of the prepared H2O2 solution and 80 μl of PBS were added to each
sample well. After 10 minutes incubation at 37°C, 100 μl of the prepared dying agents
was added. Subsequently, the plate was incubated for 15 minutes in at 37°C, and 5 μl of
the prepared sodium hydroxide solution was added to each sample well. Hydrogen
peroxide scavenging was analyzed immediately after addition of sodium hydroxide using
a plate reader at an absorbance of 610 nm (O.D. 610). Each sample was tested in
triplicate, and all selected PAs and MPAs were tested with this method.

Figure 2. General test setup for antioxidant and antimicrobial analysis on 96 well plate.
Each acid was tested in triplicate in columns 1-3, 4-6, 7-9, and 10-12 (4 acids per plate).
Samples were serially diluted from A to G; row H served as a control with no PA or
MPA.
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The antioxidant properties of PAs were quantified in terms of H2O2 scavenging
activity (Hs) using Equation 1:
𝐻" = 100% × [𝐶+ − (𝐶+.+/ × 𝐶+ )]

Equation 1

where C0 is the absorbance value of the control group with no PA and C0.05 is the
absorbance value of the PA sample at the specific concentration.

2.3 PA and MPA Antimicrobial Tests
2.3.1 Preparation of Bacteria Strains
In this study, we used Escherichia coli (E. coli), Staphylococcus epidermidis (Staph.
epi., native and drug-resistant) and Staphylococcus aureus (Staph. aureus, native and
drug-resistant) to test the efficacy of PA antimicrobial properties. Before incubating with
PAs, bacteria strains were grown in 5 ml of fresh LB broth (prepared at 25 g/L of deionized
water and autoclaved) at 37°C for ~16-17 hours. Subsequently, 1ml of the 5ml bacteria
medium was taken and cultured in 9 ml of fresh LB broth until bacteria reached the
logarithmic growth period when optical density at an absorbance of 600 nm (O.D. 600)
value equals 0.6. The O.D. value was measured using a plate reader.

2.3.2 Multi-Well Plate Assay
2.3.2.1

DMSO Bacterial toxicity

Before testing PAs antimicrobial performance, each bacteria strain was cultured
with a range of concentrations of DMSO in multi-well plates. This testing was to ensure
that DMSO does not affect the growth of bacteria strains and interfere with measurements
of PA antimicrobial efficacy, because PAs are dissolved in DMSO prior to being added to
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bacteria. Different volumes (0, 1, 2, 4, 8, 16, 32, 64, and 128 μl) of DMSO were added to
LB broth in a well; each well contained a total of 200 μl of DMSO/LB broth solution. Each
concentration of DMSO was tested in triplicate. Then, 20 μl of the prepared log-phase
growth bacteria medium was added into each well. The plate was placed in a 37°C shaker
table for 24 hours. Bacteria growth was analyzed via plate reader absorbance readings
at O.D. 600 at 0, 1, 2, 4, and 24 hours with a goal of finding the maximum volume of
DMSO that could be used in PA testing without affecting the growth of bacteria
(comparable O.D. 600 value to 0 μl samples).

2.3.2.2

PA Characterization

From the DMSO test, it was found that E. coli could be exposed to 5 μl DMSO, and
Staph. epi. and Staph. aureus could be exposed to 10 μl DMSO without negatively
affecting growth. Therefore, PAs were serially diluted from 5 to 0.078 mg/ml in 5 μl DMSO
and 95 μl of fresh LB broth for E. coli tests and in 10 μl DMSO and 90 μl of fresh LB broth
for Staph. epi. and Staph. aureus tests. Controls included wells with 5 or 10 μl DMSO in
95 or 90 μl of fresh LB broth (DMSO control), 100 μl LB broth (LB control), and a 1%
penicillin-streptomycin solution in 5 or 10 μl DMSO and LB broth (drug control). For the
drug-resistant strains, 1% methicillin or oxacillin solution was prepared in DMSO and LB
broth as additional drug controls. After that, 20 μl of prepared log-phase growth bacteria
medium and 100 μl fresh LB broth was added to all wells in the plate. Bacterial growth
was tested via absorbance readings at O.D. 600 at 0, 1, 2, 4, and 24 hours. Every sample
was tested in triplicate, and all 10 selected PAs were tested using this method. Results
were analyzed in terms of IC50 value and the log reduction values.
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IC50 is the measure of the concentration of antimicrobial agent required to kill 50% of
bacteria. It illustrates potency of inhibiting bacteria growth and provides information on
minimal concentrations required for future incorporation into antimicrobial SMP scaffolds.
IC50 was calculated with Using Equations 2 and 3:
𝐻𝑎𝑙𝑓 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =

<= ><?
@

Equation

2
𝐼𝐶50 =

CDEF GHIGJIKLDKMHI>N
D

Equation

3
where C0 is the O.D. value of DMSO group; C1 is the O.D. value of the drug control
group; b is the y-intercept of the bacteria’s growth curve relative to PA concentration; and
a is the slope of the bacteria’s growth curve relative to PA concentration.
Log reduction is the measure of how a specified concentration of antimicrobial reduces
bacteria concentration and was calculated using Equation 4:
<

𝐿𝑜𝑔 𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 = 𝐿𝑜𝑔S+ (<= )
?

Equation

4
where C0 is the O.D. value of the DMSO control and C1 is the O.D. value of a PA or
MPA.

2.3.2.3

Petri Dish Assay

Due to low solubility of PAs in aqueous solvents, sediment was observed in some
wells with higher concentration of PA samples, which affected absorbance readings in
the multi-well plate assay. Currently synthesized MPAs (modified benzoic acid, syringic
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acid, cinnamic acid, and p-coumaric acid) also had low solubility, which affected
absorbance readings. To address this issue, a Petri dish assay was applied to quantify
the antimicrobial properties of MPAs and PAs with low solubility.
LB-agar (LB at 20 g/L, agar at 15 g/L) was prepared in deionized water, autoclaved,
poured into Petri dishes, and allowed to gel overnight. Each PA for which sediment was
observed in a study with a specific bacteria strain was selected. Every selected PA was
dissolved at 5 mg/ml in 20 μl DMSO and mixed with 380 μl fresh LB broth in a 24 well
plate. Fresh LB broth (400 μl) and 20 μl DMSO in 380 μl LB broth were used as controls.
Subsequently, 40 μl of prepared log-phase growth bacteria medium was added to each
well in the plate. Each sample was tested in triplicate.
At 2, 4, and 24 hours, 10 μl of the bacteria medium was extracted from each sample
well and diluted by 10,000 in fresh LB. Then, 100 μl of the diluted solution was applied to
the surface of Petri dishes and cultured for 24 hours at 37°C. Photographs were obtained
of each plate surface after culturing, and ImageJ software was used to quantify colony
forming units (CFUs) and analyze bacteria growth.
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3. Results and Discussion
3.1 PA and MPA Antioxidant Properties
In general, reaction of hydroxyl groups with oxidizing agents (e.g. reactive oxygen
species) forms resonance-stable phenoxy radicals, which enables phenols to have
antioxidant properties.[29] Therefore, we hypothesized that PAs that do not contain
pendant hydroxyl (OH) groups (cinnamic and benzoic acid controls) would not
demonstrate antioxidant capability. In this experiment, hydrogen peroxide (H2O2) was
utilized as an oxidizing agent to quantify the antioxidant properties of 10 selected PAs.
Then, the antioxidant properties of PAs were quantified in terms of H2O2 scavenging
activity. Successful H2O2 scavenging was taken to be greater than 50%.[28]
Figure 3 shows the H2O2 scavenging capabilities of both benzoic acid (BA) and
cinnamic acid (CA) groups. From these results, the relative antioxidant capacity of PAs
can be seen in terms of H2O2 scavenging capabilities. For BA group, Figure 3A, BA does
not demonstrate antioxidant capacity, and 4-hydroxy benzoic acid (4-HBA) with only one
OH group has the second lowest antioxidant capacity. These results are in line with the
hypothesis. With the addition of methoxy and additional hydroxyl groups in protocatechuic
acid (PA), syringic acid (SYA) and vanillic acid (VA), their antioxidant efficacy is
significantly increased. The addition of functional pendant groups on PA, SYA, and VA
enables more effective formation of resonance-stabilized phenoxy radicals, which imparts
stronger antioxidant capacity. As for CA group, Figure 3B, CA does not demonstrate
antioxidant capabilities, as expected. The addition of hydrogen donating groups onto the
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other CA-based PAs resulted in significantly improved antioxidant capabilities compared
with CA.
A

B

Figure 3. Hydrogen peroxide scavenging capabilities of PAs from the (A) Benzoic acid
group and (B) Cinnamic acid group.

Upon characterization of unmodified PA antioxidant capabilities, the antioxidant
properties of modified PAs (MPAs) were characterized to test whether PAs maintain their
antioxidant capacity after the chemical modification required for incorporation into SMP
foams. Figure 4 shows the H2O2 scavenging capabilities of currently synthesized MPAs,
modified benzoic and syiringic acids from the BA group (Figure 4A) and modified
cinnamic and p-coumaric acids from the CA group (Figure 4B). From Figure 4, it can be
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seen that modified BA retains low antioxidant capacity at levels that are similar to those
of BA. Similarly, syringic acid and modified syringic acid have comparable antioxidant
efficacy. The CA group shows the same trend in that CA and modified CA both have low
H2O2 scavenging capabilities, while p-coumaric acid (P-CA) and modified P-CA have
similarly increased antioxidant properties. These results indicate that the chemical
modification of PAs that is required for their incorporation into SMP foams will not alter
their antioxidant capacity, enabling future synthesis of antioxidant SMP scaffolds.
Antioxidant SMP scaffold, as polymeric medical devices with extended biostability, have
various potential applications. Additives in SMPs that have oxygen radical scavenging
capabilities could inhibit the oxidative mechanisms of degradation, which can cause
scission and crosslinking of polyurethane chains.[35] With the presence of antioxidants
in the network, it is possible to control the SMP’s degradation. Therefore, with controlled
degrading rate, the SMPs could be made as microparticles in the drug delivery system.
For example, the SMPs with antioxidants could deliver superoxide dismutase to a model
of lung fibrosis without inflammatory response.[36] Except for the applications in the
aspect of degradation, the antioxidant SMP scaffolds also have healing benefits. Studies
have shown that the onset of varieties of diseases such as rheumatoid arthritis,
atherosclerosis, and cancer is related to the presence of free radicals and excess reactive
oxygen species. The development of SMP scaffolds with antioxidants could help lower
the concentration of these compounds. Moreover, the excess amount of reactive oxygen
species is able to prevent the process of wound healing, the antioxidants-present SMPs
could help overcome this problem.[37]
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A

B

Figure 4. Hydrogen peroxide scavenging capabilities of MPAs from the (A) Benzoic
acid group and (B) Cinnamic acid group in comparison to their unmodified controls.

3.2 PA and MPA Antimicrobial Properties
3.2.1 DMSO Bacterial Toxicity
Before testing PA and MPA antimicrobial properties, a test was run with each bacteria
strain to find the maximum volume of DMSO that could be used to dissolve PAs and
MPAs without affecting bacteria growth. Figure 5 shows the DMSO test results over 24
hours with the 5 selected bacteria strains (E. coli; Staph. epi., native and drug-resistant;
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Staph. aureus, native and drug-resistant). From the data, we could see that the different
bacteria strains have variable maximum DMSO volume tolerance. For E. coli in Figure
5A, the O.D. values (i.e. bacteria density) with exposure to 8 μl DMSO are comparable to
those of the control group (0 μl DMSO) over 24 hours; however, the O.D. values were
greatly decreased compared to the control group with exposure to 16 μl DMSO. Therefore,
each concentration of PAs was dissolved in 5 μl DMSO for E. coli tests to ensure that
DMSO did not affect PA characterization. In Figure 5B, it can be seen that the O.D.
values for Staph. epi. native strain did not show great decrease compared with the control
group over 24 hours with exposure to up to 16 μl DMSO. In Figure 5C, 16 μl DMSO did
not affect Staph. epi. drug-resistant strain growth at 4 hours, and a slight increase in
growth can be observed at 24 hours with 16 μl DMSO. These results were attributed to
the fact that different organisms will respond individually to the same amount and
concentration of one particular organic solvent.[38] Therefore, PAs were dissolved in 10
μl DMSO for both Staph. epi. native and drug-resistant strains. From Figure 5D, 16 μl
DMSO did not greatly affect the O.D. value for Staph. aureus over 4 hours compared with
the control group, but bacteria growth was decreased at 24 hours for all concentrations
of DMSO. From Figure 5E, 16 μl DMSO slightly decreased the O.D. values for drugresistant Staph. aureus over 24 hours, to the lesser extent than the 32 μl DMSO. In
consideration of PA’s solubility and these results, PAs were dissolved in 10 μl DMSO for
testing with Staph. aureus native and drug-resistant strains.
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Drug-Resistant

Native

E. coli

A

C

D

E

Staph. aureus

Staph. epi.

B

Figure 5. DMSO maximum volume test over 24 hours with (A) E. coli, (B) Staph. epi.
native strain, (C) Staph. epi. drug-resistant strain, (D) Staph. aureus native strain, and
(E) Staph. aureus drug-resistant strain.
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3.2.2 PA IC50
Upon determination of appropriate amounts of DMSO for each test, the antimicrobial
properties of PAs and MPAs were characterized in terms of IC50 value (concentration
required to kill 50% of cells) and log reduction value (number of cells killed in comparison
with media control).
The IC50 results are shown in Figures 6-7. The lack of data for CA and CAA is
because of limited solubility and color change that affected absorbance measurements.
From Figure 6A and 6B, it can be seen that the IC50 value of each PA have increased
from 4 to 24 hours, which means PA antimicrobial capabilities generally decrease with
time for E. coli and Staph. epi., In particular, protocatechuic acid (PA) and syringic acid
(SYA) in the BA group and ferulic acid (FA) and sinapic acid (SA) in the CA group show
large decreases in antimicrobial properties with time. These reductions in efficacy over
time are likely due to a combination of bacterial uptake of PA to reduce effective
concentration during live bacterial growth. As shown in Figure 6C, the IC50 value of each
PA have decreased between 4 to 24 hours, which means PA’s antimicrobial capabilities
increase with time for Staph. aureus. From Figure 7A, we can see that the IC50 value of
each PA decreased from 4 to 24 hours for drug-resistant Staph. epi., indicating that PAs
have increased antimicrobial capabilities over time with this bacterial strain. The opposite
trend can be viewed in Figure 7B, where PA IC50s increase from 4 to 24 hours, indicating
decreased antimicrobial capacity over time with drug-resistant Staph. aureus.
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Figure 6. IC50 results of (left) Benzoic acid group and (right) Cinnamic acid group
against native (A) E. coli, (B) Staph. epi., and (C) Staph. aureus.
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Figure 7. IC50 results of (left) Benzoic acid group and (right) Cinnamic acid group
against drug-resistant (A) Staph. epi. and (B) Staph. aureus.

It could be observed from the experiment that CA solubility improved over time in the
presence of bacteria strains, and CA solubility didn’t change without the presence of
bacteria. This finding could provide the basis of future studies, for example, an experiment
could be designed to test if the solubility change is due to digestion by bacterial proteases,
and a mutant strain that doesn’t release protease could be applied in the test. Also, it
could be tested if CA is taken up over time, spectroscopy techniques could be applied to
analyze CA’s concentration over time.
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Three important results that can be gleaned from this data include: (1) All PAs show
some efficacy against all tested bacteria strains, indicating their potential for use in wound
infection prevention. (2) PA IC50 values are within the range of possible incorporation
into SMP scaffolds, and (3) PAs are equally effective against native and drug-resistant
strains of Staph. epi. and Staph. aureus. Beyond this project, this study provides essential
information that could be utilized in PA use in other biomaterial systems to provide
localized antimicrobial properties.
Except for the polymers with improved antimicrobial properties demonstrated above,
phenolic acids could also incorporate with natural rubber (NR) forming SMPs with tunable
triggering temperature. They can form a epoxidized natural rubber crosslinked network
with excellent shape memory effect.[39]

3.2.3 Log Reduction
Bacterial log reductions in the presence of the selected PAs are shown in Figures
8-9.
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Figure 8. Native (A) E. coli, (B) Staph. epi., and (C) Staph. aureus log reduction in
presence of (left) Benzoic acid group and (right) Cinnamic acid group at 5 mg PA/ml.
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Figure 9. Drug-resistant (A) Staph. epi. and (B) Staph. aureus log reduction in presence
of (left) Benzoic acid group and (right) Cinnamic acid group at 5 mg PA/ml.

The data collected in Figure 8 is based on the O.D. value of 5 mg/ml PA solutions
collected in the 96 well plate, the lack of some data is due to solubility issues that affected
absorbance measurements. In general, a larger log reduction corresponds with improved
antimicrobial capacity. From Figure 8A, except for the PAs without log reduction data,
only BA shows consistently increased antimicrobial capability over the full 24 hours for E.
coli. However, all PAs with available data show a log reduction of ~0.8 at 4 hours, which
is comparable to that of the drug control, indicating initial antimicrobial properties at
clinically effective levels. In contrast, Figure 8B and 8C show that the log reduction value
and antimicrobial capability of all tested PAs increased with time for Staph. epi. and Staph.
aureus. These differences are likely due to differences in bacterial growth rates.
Additionally, the uptake of PAs into gram positive bacteria (Staph. epi. and Staph. aureus)
may be more effective than that into gram negative E. coli due to differences in the cell
walls. Based on the potential mechanisms of PA’s antimicrobial properties, the
differences in bacterial cell cytoplasmic membranes can indeed affect the antibacterial
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properties of PA. Because PAs could alter bacteria’s surface tension components, they
can also change the hydrophobicity and electron receptors (receptor components
increase on gram-positive, decrease on gram-negative) on the bacterial cell surface.
Therefore, gram negative E. coli shows different results compared with other bacteria
strains. In Figure 9A and 9B, it can be seen that the antimicrobial capability of each PA
is increased over time for drug-resistant Staph. epi. and Staph. aureus to comparable
levels to those seen in the native strains. These results confirm the IC50 results and show
that only 5 mg PA/ml is required for effective antimicrobial properties at levels that are
comparable to drugs. Previously synthesized SMP foams with cinnamic acid contained
between ~5 and 20 mg CA/ml (cm3) of foam.
Compared with those previously presented in the literature, the antimicrobial results
of CA in this paper show the same outstanding antimicrobial properties on E. coli and
Staph. epi..[27] However, there are also some differences, some results in previous
literature show that protocatechuic acid demonstrates high antimicrobial capacity on
gram-positive bacteria strains,[40] which could not be seen in the results of this paper.
According to PA’s antimicrobial mechanisms, one possible explanation for this
difference could be the different proportions of lipids and phospholipids contained in the
cell walls of the bacteria strain (Bacillus cereus) used in the previous literature.[41]

3.2.4 Colony Forming Units
The antimicrobial properties of PAs with limited solubility (cinnamic acid (CA), sinapic
acid (SA), p-coumaric acid (PCA), and syringic acid (SYA)) and the synthesized MPAs
(modified benzoic acid (BA), SYA, CA, and PCA) could not be measured directly using
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the multi-well plate assay. The sediment that was present with these PAs and MPAs
blocked the travel of light through the sample, affecting measurements of bacteria density
via absorbance. Therefore, a Petri dish assay is utilized to quantify the antimicrobial
properties of PAs and MPAs with limited solubility in terms of colony forming units (CFUs)
over time, as shown in Figures 10-12.
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Figure 10. CFU counts of (A) E. coli, (B) native Staph. epi., (C) native Staph. aureus,
(D) drug-resistant Staph. epi., and (E) Drug-resistant Staph. aureus after exposure to
PAs with limited solubility.

The CFU results were quantified based off of ¼ the plate area using ImageJ software.
Compared with LB and DMSO, it could be seen that all PAs with limited solubility are
effective for 5 selected bacteria strains to levels that are comparable to the penicillin
control, with the exception of SA and E. coli, Figure 10. In general, CA shows the best
antimicrobial property among all the PAs with limited solubility, as there were no visible
CFUs after 24 hours of exposure to CA. Again, comparable efficacy was observed with
native and drug-resistant strains, indicating PA efficacy against drug-resistant bacteria,
even when not fully solubilized.
The CFU results of MPAs in comparison with their PA controls are shown on Figures
11 (native strains) and 12 (drug-resistant strains). All MPAs showed comparable results
to their corresponding PAs for all bacteria strains. In general, PAs and MPAs were highly
effective and reducing bacteria CFUs in the gram-positive strains (native and drugresistant). Except for E. coli, PAs were clearly effective at reducing bacterial CFUs in

30
comparison with LB and DMSO. It should be noted that the unmodified PA CFU results
are different from those observed in Figure 10. Thus, these studies should be repeated
to verify PA efficacy against E. coli. However, the comparable CFU trends between PAs
and corresponding MPAs over 24 hours of exposure indicates that PA modification at the
carboxylic acid group, which is required for incorporation into SMPs, does not alter
antimicrobial characteristics.
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group.
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4. Conclusion
These studies provide the first systematic characterization of PAs in terms of
structure and antioxidant and antimicrobial properties with an emphasis on antimicrobial
efficacy against common wound pathogens. The data collected thus far on modified PAs
indicates that the carboxylic acid groups on PAs can be reacted with SMP components
without loss in antioxidant or antimicrobial functionality. In general, hydrogen peroxide
scavenging capabilities of phenolic acids increase with increasing radical scavenging
pendant groups, eliminating cinnamic, benzoic, and 4-hydroxy benzoic acids as potential
antioxidants. No consistent trends were observed between antimicrobial capacity and PA
structure. While all PAs showed efficacy against all tested strains, there were variations
in antimicrobial properties. PAs that had IC50 values greater than 10 mg/ml, maximum
log reduction values below 0.7, and/or CFU counts above 100 include sinapic acid,
syringic acid, and protocatachuic acid. Thus, these PAs will not be pursued in future
studies required for antimicrobial SMPs. While solubility did not show a direct effect on
functionality, limited solubility can hinder effective reactions between PAs and SMP
components. Those PAs which have limited solubility include cinnamic acid, sinapic acid,
p-coumaric acid, and syringic acid. Thus, these PAs will be given lower priority in future
studies. Based on these trends, ferulic, caffeic, and vanillic acids will be pursued in future
studies of synthesis of antioxidant and antimicrobial SMPs for use in hemorrhage control,
Figure 13. This thesis provides a foundation for rational design of PA-containing
biomaterial scaffolds with desired functionality that could be used in a range of
applications where antioxidant and/or antimicrobial properties are required for improved
clinical outcomes.
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Figure 13. PA library down-selection for future incorporation into SMPs. Grey bars: No
antioxidant efficacy. Red bars: Reduced antimicrobial efficacy. Blue bars: Limited
solubility.

This research will guide future research on the rational synthesis of function foams
with antioxidants, more studies could be on the synthesizing processes of improving PA
content into the SMPs, which will enable SMPs to have better desired charasteristics.
With the secreeing of 10 selected PAs, the PA library has been narrowed, which will help
the future incorporating selection. Also, this research provides new fundamental
information on PA structure/prooerty relationships, especially the relationship between
PA structures and antioxidant properties. The future direction of this research is to test
multiple bacteria strains together and test with biofilms. Because the battlefiled is a
complicated enviroment, multiple bacteria strains may form a complex system.
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